Fidelity Select Pharmaceuticals (FPHAX)
Stock analysis · NASDAQ · Financial Services · Asset Management
Fidelity Select Pharmaceuticals (FPHAX) is a publicly traded company in the Financial Services sector. Latest price: $37.58. Market cap $1.35B. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Proprietary Signals
About Fidelity Select Pharmaceuticals
This fund typically allocates a minimum of 80% of its capital to entities involved in the pharmaceutical sector, encompassing activities from scientific discovery and development to manufacturing and distribution of various medicinal products. Its holdings include both domestic and international companies, with the portfolio primarily consisting of common equities. Investment decisions are guided by a thorough fundamental analysis, assessing aspects like a company's financial health, its standing within the industry, and broader market and economic trends. It operates as a non-diversified portfolio.
Peers
Recent News
- No recent news available.
Related
Browse more tickers: sitemap